Related Experiment Video
Updated: Mar 30, 2026

Osmotic Drug Delivery to Ischemic Hindlimbs and Perfusion of Vasculature with Microfil for Micro-Computed Tomography Imaging
Published on: June 29, 2013
Livedoid Vasculopathy with Hyperhomocysteinemia Responding to Hyperbaric Oxygen Therapy
Rahul Ray1, Aseem Sharma1, Biju Vasudevan1
1Department of Dermatology, INHS Asvini, Mumbai, Maharashtra, India.
This case study highlights hyperbaric oxygen therapy as a novel treatment for livedoid vasculopathy, a rare leg ulcer condition. The therapy showed significant improvement in a patient with chronic, recurrent ulcers.
Area of Science:
- Dermatology
- Vascular Medicine
Background:
- Livedoid vasculopathy is a rare chronic condition causing painful leg ulcers.
- It often presents with a reticular pattern and can lead to scarring.
Purpose of the Study:
- To present a case of livedoid vasculopathy treated with hyperbaric oxygen therapy.
- To explore hyperbaric oxygen therapy as a novel treatment option for this condition.
Main Methods:
- A 30-year-old male with a 6-year history of leg ulcers underwent investigation.
- Skin biopsy confirmed livedoid vasculopathy with elevated homocysteine levels.
- The patient received hyperbaric oxygen therapy after recurrence post-corticosteroid treatment.
Main Results:
- The patient exhibited multiple ulcers in a reticular pattern on both lower legs, ankles, and feet.
- Hyperbaric oxygen therapy led to a very good response in ulcer healing.
- This treatment offers a novel approach for recalcitrant livedoid vasculopathy.
Conclusions:
- Hyperbaric oxygen therapy is a promising novel treatment for livedoid vasculopathy.
- This case adds to the limited literature on hyperbaric oxygen therapy for this rare condition.
Related Concept Videos
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Varicose Veins II: Diagnostic Studies and Interprofessional Care
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

